<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00969631</url>
  </required_header>
  <id_info>
    <org_study_id>MU- 012</org_study_id>
    <secondary_id>FMH-009-C</secondary_id>
    <nct_id>NCT00969631</nct_id>
  </id_info>
  <brief_title>Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS)</brief_title>
  <official_title>Combined Metformin and Clomiphene Citrate Versus Laparoscopic Ovarian Diathermy for Ovulation Induction in Clomiphene-resistant Women With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare and determine the efficacy of combined metformin and
      Clomiphene citrate administration to that of laparoscopic ovarian diathermy (LOD) in
      infertile women with Polycystic ovary syndrome (PCOS) not responding to treatment with
      Clomiphene alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients in the combined metformin-CC group received metformin HCl (Cidophage速;Chemical
      Industries Development,Cairo, Egypt), 500 mg thrice daily for 6-8 weeks. Then after the end
      of this period, they received 100 mg CC (Clomid速; Global Napi Pharmaceuticals,Cairo, Egypt)
      for 5 days starting from day 3 of menstruation (increased by 50 mg in the next cycle in case
      of anovulation ). Patients continued treatment for up to six cycles. Metformin was stopped
      only when pregnancy was documented. All patients in the control group underwent laparoscopic
      ovarian diathermy, then followed up for 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence of ovulation and midcycle endometrial thickness (mm).</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>occurrence of pregnancy, miscarriage, multiple pregnancy and live birth rates.</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">282</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>Metformin-CC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic ovarian diathermy (LOD)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metformin HCl (Cidophage速; CID,Cairo, Egypt), CC (Clomid速; Global Napi Pharmaceuticals,Cairo, Egypt),Cairo, Egypt)</intervention_name>
    <description>metformin HCl 1500 daily for 6-8 weeks then 100 mg CC for 5 days starting from day 3 of menstruation up to 6 cycles.</description>
    <arm_group_label>Metformin-CC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic ovarian diathermy (LOD)</intervention_name>
    <description>Three-puncture technique. Each ovary was cauterized at four points, each for 4 seconds at 40 W for a depth of 4 mm with a mixed current, using an monopolar electrosurgical needle.</description>
    <arm_group_label>Laparoscopic ovarian diathermy (LOD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CC resistant PCOS

        Exclusion Criteria:

          -  Congenital adrenal hyperplasia

          -  Cushing syndrome

          -  Androgen secreting tumors
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hatem Abu Hashim, MD. MRCOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Naser El Lakany, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lotfi Sherief, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura University Hospitals, OB/GYN department</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia Governorate</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Siebert TI, Kruger TF, Steyn DW, Nosarka S. Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. Fertil Steril. 2006 Nov;86(5):1432-7. Epub 2006 Sep 27. Review.</citation>
    <PMID>17007847</PMID>
  </reference>
  <reference>
    <citation>Bayram N, van Wely M, Kaaijk EM, Bossuyt PM, van der Veen F. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ. 2004 Jan 24;328(7433):192.</citation>
    <PMID>14739186</PMID>
  </reference>
  <reference>
    <citation>Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P. Laparoscopic 'drilling' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001122. Review. Update in: Cochrane Database Syst Rev. 2012;6:CD001122.</citation>
    <PMID>17636653</PMID>
  </reference>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2009</study_first_submitted>
  <study_first_submitted_qc>August 31, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2009</study_first_posted>
  <last_update_submitted>August 31, 2009</last_update_submitted>
  <last_update_submitted_qc>August 31, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Hatem Abu Hashim, Associate Prof. of OB/GYN</name_title>
    <organization>Mansoura Faculty of Medicine, Mansoura University.</organization>
  </responsible_party>
  <keyword>Polycystic ovary syndrome</keyword>
  <keyword>clomiphene resistance</keyword>
  <keyword>metformin</keyword>
  <keyword>laparoscopic ovarian diathermy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

